- Home
- MEC vs TSHA Comparison
MEC vs TSHA Comparison
Compare MEC & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEC
- TSHA
- Stock Information
- Founded
- MEC 1945
- TSHA 2019
- Country
- MEC United States
- TSHA United States
- Employees
- MEC N/A
- TSHA N/A
- Industry
- MEC Industrial Specialties
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- MEC Industrials
- TSHA Health Care
- Exchange
- MEC Nasdaq
- TSHA Nasdaq
- Market Cap
- MEC 249.1M
- TSHA 397.8M
- IPO Year
- MEC 2019
- TSHA 2020
- Fundamental
- Price
- MEC $14.36
- TSHA $2.10
- Analyst Decision
- MEC Strong Buy
- TSHA Strong Buy
- Analyst Count
- MEC 3
- TSHA 8
- Target Price
- MEC $20.00
- TSHA $6.63
- AVG Volume (30 Days)
- MEC 105.9K
- TSHA 2.9M
- Earning Date
- MEC 05-06-2025
- TSHA 05-16-2025
- Dividend Yield
- MEC N/A
- TSHA N/A
- EPS Growth
- MEC 160.08
- TSHA N/A
- EPS
- MEC 1.08
- TSHA N/A
- Revenue
- MEC $555,914,000.00
- TSHA $8,333,000.00
- Revenue This Year
- MEC N/A
- TSHA N/A
- Revenue Next Year
- MEC $9.48
- TSHA N/A
- P/E Ratio
- MEC $13.30
- TSHA N/A
- Revenue Growth
- MEC N/A
- TSHA N/A
- 52 Week Low
- MEC $11.72
- TSHA $1.05
- 52 Week High
- MEC $23.02
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- MEC 65.24
- TSHA 58.01
- Support Level
- MEC $12.70
- TSHA $1.85
- Resistance Level
- MEC $13.66
- TSHA $2.73
- Average True Range (ATR)
- MEC 0.68
- TSHA 0.27
- MACD
- MEC 0.23
- TSHA 0.04
- Stochastic Oscillator
- MEC 92.30
- TSHA 58.47
About MEC Mayville Engineering Company Inc.
Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.